clindamycin phosphatedrugHigh PriorityActive

Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC# 51672-4081-4

clindamycin phosphate Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC# 51672-4081-4 recalled by FDA. Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.

By RecallRadar Editorial Team

Sourced from FDA. Last reviewed March 4, 2026.

This recall involves safety concerns. Take action promptly.

✨ Plain-English Summary

Is This Recall Still Active?

Status: Yes - Active

This recall is currently active. If your device matches the affected models, follow the official instructions as soon as possible.

Source & Verification

This page summarizes the official notice and keeps key facts easy to verify.

Official source: FDA
Announced by source: November 26, 2025
Last reviewed by RecallRadar: March 4, 2026

What You Should Do

1## Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC# 51672-4081-4 Agency: FDA | Category: drug Reason: Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay. What to do:
2Stop using the product if your lot/model matches.
3Check the FDA notice for specifics.
4Follow remedy instructions.

Open Official Recall Notice Get Alerts for clindamycin phosphate Devices

What's Being Recalled

Quoted source excerpt from the official notice.

Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay.

Who's Affected

Specific models and identifiers listed in the source notice:

Model #1

Lot#: AD30154, AD31143, AD31145, Exp 11/30/2025

#	Model
1	Lot#: AD30154, AD31143, AD31145, Exp 11/30/2025

Technical model codes are manufacturer identifiers. Match both the product name and model code from your device settings, label, or packaging.

Frequently Asked Questions

Is my clindamycin phosphate device affected?

Check the affected models section on this page. The official notice currently lists Lot#: AD30154, AD31143, AD31145, Exp 11/30/2025.

What is the remedy for this recall?

## Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC# 51672-4081-4 Agency: FDA | Category: drug Reason: Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay. What to do: 1. Stop using the product if your lot/model matches. 2. Check the FDA notice for specifics. 3. Follow remedy instructions.

Where can I verify recall details?

Use the official source link in this page to confirm dates, eligibility, and next steps: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Keep browsing with these internal hubs: clindamycin phosphate recall hub and Food & Drug recall hub.